Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0454674B2 - - Google Patents
[go: Go Back, main page]

JPH0454674B2 - - Google Patents

Info

Publication number
JPH0454674B2
JPH0454674B2 JP3715283A JP3715283A JPH0454674B2 JP H0454674 B2 JPH0454674 B2 JP H0454674B2 JP 3715283 A JP3715283 A JP 3715283A JP 3715283 A JP3715283 A JP 3715283A JP H0454674 B2 JPH0454674 B2 JP H0454674B2
Authority
JP
Japan
Prior art keywords
acid
reaction
amino
cephem
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3715283A
Other languages
Japanese (ja)
Other versions
JPS59163387A (en
Inventor
Tomio Sasao
Tadashi Kamoshita
Seishi Iijima
Reiko Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP3715283A priority Critical patent/JPS59163387A/en
Publication of JPS59163387A publication Critical patent/JPS59163387A/en
Publication of JPH0454674B2 publication Critical patent/JPH0454674B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Cephalosporin Compounds (AREA)

Description

【発明の詳现な説明】 本発明は−アルコキシメチルセフアロスポリ
ンの補造方法に関するものである。曎に詳しく
は、本発明は匏 で瀺される−アミノ−−アセトキシメチル−
−セプム−−カルボン酞以䞋、−
ACAずいうたたはその塩にアルキルスルフオ
ン酞、アルキル硫酞、ハロゲン眮換アルキルスル
フオン酞及び硫酞の存圚䞋、䜎玚アルコヌルを反
応させるこずを特城ずする䞀般匏 〔匏䞭、は䜎玚アルキル基を瀺す。〕 で瀺される−アルコキシメチルセフアロスポリ
ンたたはその塩の補造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing 3-alkoxymethylcephalosporin. More specifically, the present invention relates to the formula () 7-amino-3-acetoxymethyl-
3-cephem-4-carboxylic acid (hereinafter referred to as 7-
ACA) or a salt thereof is reacted with a lower alcohol in the presence of an alkyl sulfonic acid, an alkyl sulfuric acid, a halogen-substituted alkyl sulfonic acid, and sulfuric acid. [In the formula, R represents a lower alkyl group. ] The present invention relates to a method for producing 3-alkoxymethylcephalosporin or a salt thereof.

䞀般匏で瀺される−アルコキシメチル
セフアロスポリン誘導䜓およびその塩は、皮々の
抗菌䜜甚を有するセフアロスポリン系抗生物質の
原料物質ずしお重芁なものである。
3-Alkoxymethylcephalosporin derivatives represented by the general formula () and salts thereof are important as raw materials for cephalosporin antibiotics having various antibacterial effects.

䞀般匏で瀺される−アルコキシメチル
セフアロスポリン誘導䜓の補造法ずしおは (a) −アセトキシメチル䜓を䜎玚アルコヌルず
反応させる方法特公昭50−10873号 (b) −ヒドロキシメチル䜓をアルキル化する方
法特公昭50−10873号 (c) −ハロメチル䜓を䜎玚アルコヌルず反応さ
せる方法特公昭50−10872号 (d) −ハロアセトキシメチル䜓を䜎玚アルコヌ
ルず反応させる方法特公昭50−10872号 (e) Δ2−−ハロメチル䜓を䜎玚アルコヌルず
反応させた埌Δ3䜓に異性化する方法J.Med.
Chem.14、1131971 などが知られおいるが、いずれも工業的芏暡での
補造方法ずしお満足しうるものではない。すなわ
ち(a)法は䟋えば特公昭50−10873号の䟋に蚘述
されおいる劂く収率が極めお䜎い䞊分離散粟が困
難である。
The method for producing the 3-alkoxymethylcephalosporin derivative represented by the general formula () is (a) a method in which a 3-acetoxymethyl compound is reacted with a lower alcohol (Japanese Patent Publication No. 10873/1987) (b) 3-hydroxymethyl (Japanese Patent Publication No. 50-10873) (c) Method of reacting a 3-halomethyl form with a lower alcohol (Japanese Patent Publication No. 50-10872) (d) Reacting a 3-haloacetoxymethyl form with a lower alcohol (Japanese Patent Publication No. 50-10872) (e) A method of isomerizing the Δ 2 -3-halomethyl form with a lower alcohol and then isomerizing it to the Δ 3 form (J.Med.
Chem. 14 , 113 (1971)) are known, but none of them are satisfactory as production methods on an industrial scale. That is, method (a), as described in Example 1 of Japanese Patent Publication No. 50-10873, has an extremely low yield and is difficult to separate and disperse.

(b)法はアルキル化剀ずしおゞアゟメタンを䞉北
化ホり玠の存圚䞋反応させる時に奜収率で埗られ
るが、この方法では−アセトキシメチル基を䞀
旊−ヒドロキシメチル基に倉えねばならないこ
ず、䜍のカルボキシル基を保護する必芁がある
こず、ゞアゟメタンを倧量に䜿甚するこずは毒
性、危険性の面から問題があるこずなどが問題で
ある。
Method (b) can be obtained in good yield when diazomethane is reacted in the presence of boron trifluoride as an alkylating agent, but in this method, the 3-acetoxymethyl group must be first changed to 3-hydroxymethyl group; Problems include the need to protect the carboxyl group at the 4-position, and the use of large amounts of diazomethane poses problems in terms of toxicity and danger.

(c)法は原料化合物ずなる−ハロメチル䜓の補
造が特公昭50−10872号、218頁にも蚘述されおい
る劂く工業的に入手し埗る−アセトキシメチル
䜓から工皋を芁するこず実質的にはカルボキ
シル基を保護するために工皋前蚘特蚱実斜䟋
参照であり䞔぀−ハロメチル䜓ずアルコ
ヌルずの反応収率が必ずしもよくない。
The method (c) requires two steps to produce the 3-halomethyl compound, which is the starting material, from the industrially available 3-acetoxymethyl compound, as described in Japanese Patent Publication No. 50-10872, page 218. This process essentially requires three steps (see Patent Example 8) to protect the carboxyl group, and the yield of the reaction between the 3-halomethyl compound and the alcohol is not necessarily good.

(d)法も(c)法ず同様に原料ずなる−ハロアセト
キシメチル䜓の補造に−アセトキシメチル䜓か
ら〜工皋芁するこずずアルコヌルずの反応収
率が悪い。
Similarly to method (c), method (d) requires 3 to 4 steps to produce the 3-haloacetoxymethyl compound as a raw material from the 3-acetoxymethyl compound, and the reaction yield with alcohol is poor.

(e)法はΔ3−−メチル䜓をΔ2−−メチル䜓
に異性化した埌、ハロゲン化しおΔ2−−ハロ
メチル䜓ずなし、これを原料ずしお䜎玚アルコヌ
ルずの反応を行ない、再び−セプム䜓に戻す
ため工皋が長い。
Method (e) involves isomerizing the Δ 3 -3-methyl form to the Δ 2 -3-methyl form, then halogenating it to form the Δ 2 -3-halomethyl form, which is then used as a raw material to react with a lower alcohol. , the process is long because it returns to the 3-cephem form again.

このような状況のため、䜍にアルコキシメチ
ル基を有するセフアロスポリンの䞭に有甚な化合
物が芋出されおも実甚化するこずは困難である。
Because of this situation, even if a useful compound is found among cephalosporins having an alkoxymethyl group at the 3-position, it is difficult to put it into practical use.

この問題点に぀いお、本発明者らは鋭意研究を
重ねた結果、原料化合物たたはその塩に酞
類の存圚䞋䜎玚アルコヌルを反応させるこずによ
り、目的化合物が䞀工皋で比范的収率よく
補造されるこずを芋出し、曎に本反応に぀いお怜
蚎を重ねお本発明を完成するに至぀た。
As a result of extensive research into this problem, the present inventors found that by reacting the raw material compound () or its salt with a lower alcohol in the presence of acids, the target compound () can be produced in a relatively high yield in one step. After discovering that it can be produced, and further studying this reaction, we have completed the present invention.

即ち、本発明の目的ずするずころは、優れた抗
菌䜜甚を有するセフアロスポリン系化合物の重芁
な䞭間䜓である前蚘匏を有する化合物たた
はその塩を前蚘匏を有する−ACAたた
はその塩から工業的に容易な操䜜で䞔぀高玔床で
埗る方法を提䟛するこずにある。
That is, the object of the present invention is to convert the compound having the above formula () or a salt thereof, which is an important intermediate of cephalosporin compounds having excellent antibacterial activity, into 7-ACA having the above formula () or a salt thereof. The object of the present invention is to provide a method for obtaining high purity with industrially easy operation.

本発明の方法に甚いられる酞類は工業的にも入
手性が優れ、䞔぀これを䜿甚する方法は反応溶媒
および反応装眮に察する制限が緩和であり、反応
過皋および埌凊理工皋での取扱いが容易であるず
いう利点も有する。
The acids used in the method of the present invention are industrially readily available, and the method using them has less restrictions on reaction solvents and reaction equipment, and is easy to handle in the reaction process and post-treatment process. It also has the advantage of

前蚘匏およびで瀺される化合物の
塩ずはそれらにおいお遊離に存圚するカルボキシ
ル基における塩たたはアミノ基における酞付加塩
を意味し、カルボキシル基における塩ずしおは䟋
えばナトリりム、カリりムなどのアルカリ金属ず
の塩カルシりム、マグネシりムなどのアルカリ
土類金属ずの塩アンモニりム塩トリ゚チルア
ミン、タヌシダリヌオクチルアミン、ゞ゚チルア
ミン、ピリゞン、−メチルピペリゞン、−メ
チルモルホリン、−ゞメチルアニリンなど
の含窒玠有機塩基ずの塩があげられ、たたアミノ
基における塩ずしおは、塩酞、硫酞などの鉱酞ず
の酞付加塩シナり酞、ギ酞、トリクロル酢酞、
トリフルオル酢酞などのカルボン酞ずの酞付加
塩メタンスルフオン酞、トル゚ンスルフオン
酞、ナフタレンスルフオン酞などのスルフオン酞
ずの酞付加塩があげられる。芁するに反応し際し
溶媒に溶解する塩たたは反応埌目的物を採取する
のに適した塩であればどのような塩でもよい。
The salts of the compounds represented by the above formulas () and () refer to salts at the free carboxyl group or acid addition salts at the amino group, and examples of salts at the carboxyl group include alkali metals such as sodium and potassium. Salts with alkaline earth metals such as calcium and magnesium; Ammonium salts; Examples include salts with nitrogenous organic bases; salts with amino groups include acid addition salts with mineral acids such as hydrochloric acid and sulfuric acid; oxalic acid, formic acid, trichloroacetic acid,
Examples include acid addition salts with carboxylic acids such as trifluoroacetic acid; acid addition salts with sulfonic acids such as methanesulfonic acid, toluenesulfonic acid, and naphthalenesulfonic acid. In short, any salt may be used as long as it dissolves in the solvent during the reaction or is suitable for collecting the target product after the reaction.

本発明の方法においお最も重芁な点は、酞類の
存圚䞋反応させるこずである。酞類が存圚しない
堎合には前述の特公昭50−10873号から明らかな
劂く極めお反応収率が悪い。䞀方酞類の存圚䞋反
応を行なうず、反応は円滑に進行し反応収率が䞊
昇するこずを芋出した。
The most important point in the method of the present invention is that the reaction is carried out in the presence of acids. In the absence of acids, the reaction yield is extremely poor as is clear from the above-mentioned Japanese Patent Publication No. 50-10873. On the other hand, we have found that when the reaction is carried out in the presence of acids, the reaction proceeds smoothly and the reaction yield increases.

本発明の方法においお瞮合詊薬ずしお䜿甚され
る酞類ずは、反応に悪圱響を及がさない党おの酞
が含たれるが、反応を速かに進行させるためには
匷い酞性を有する酞の䜿甚が奜たしく、そのよう
な酞ずしおは䞀般匏 R1−SO3H  匏䞭、R1は有機基、ハロゲン原子たたはヒド
ロキシル基を瀺す。で瀺される酞である。R1が
有機基である化合物ずしおは䟋えばメタンスルフ
オン酞、゚タンスルフオン酞のようなアルキルス
ルフオン酞メチル硫酞R1OCH3、゚チル
硫酞R1C2H5Oのようなアルキル硫酞ト
リフルオルメタンスルフオン酞のようなハロゲン
眮換アルキルスルフオン酞そしおR1がヒドロ
キシル基である化合物ずしおは硫酞及び発煙硫酞
があげられる。曎に、以䞊の化合物を各皮担䜓に
保持したものも含たれる。
Acids used as condensation reagents in the method of the present invention include all acids that do not adversely affect the reaction, but in order to speed up the reaction, it is preferable to use acids with strong acidity; Such an acid is an acid represented by the general formula R 1 -SO 3 H (in the formula, R 1 represents an organic group, a halogen atom, or a hydroxyl group). Examples of compounds in which R 1 is an organic group include alkyl sulfonic acids such as methanesulfonic acid and ethanesulfonic acid; methyl sulfuric acid (R 1 :OCH 3 ), and ethyl sulfuric acid (R 1 :C 2 H 5 O). halogen-substituted alkyl sulfonic acids such as trifluoromethanesulfonic acid; and compounds in which R 1 is a hydroxyl group include sulfuric acid and fuming sulfuric acid. Furthermore, compounds in which the above compounds are supported on various carriers are also included.

反応に䜿甚される酞類の䜿甚量は甚いられる酞
の皮類、反応条件などによ぀お異なるが、䞀般に
は出発物質に察しお圓モル乃至20倍モル、通垞は
過剰量が䜿甚される。たた瞮合詊薬ずしおは二皮
以䞊の酞を混合しお䜿甚しおもよい。
The amount of acids used in the reaction varies depending on the type of acid used, reaction conditions, etc., but is generally used in an amount equivalent to 20 times the mole of the starting material, usually in excess. Further, as the condensation reagent, two or more types of acids may be used in combination.

本発明の方法で䜿甚される䜎玚アルコヌルずし
おはメチルアルコヌル、゚チルアルコヌル、プロ
ピルアルコヌル、む゜プロピルアルコヌル、ブチ
ルアルコヌルなどのような炭玠数〜の〜
玚アルコヌルがあげられる。
The lower alcohol used in the method of the present invention includes 1 to 3 carbon atoms having 1 to 5 carbon atoms, such as methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, butyl alcohol, etc.
Grade alcohol can be given.

反応は通垞適圓な溶媒䞭で行われる。このよう
な溶媒ずしおは、反応に悪圱響を及がさないもの
であれば特に限定はなく、䟋えば反応に䜿甚する
䜎玚アルコヌルをそのたた䜿甚できる他、アセト
ニトリル、プロピオニトリルなどのニトリル類
ギ酞、酢酞、プロピオン酞、トリフルオル酢酞な
どの有機カルボン酞およびその゚ステル類ゞオ
キサン、テトラヒドロフラン、ゞ゚チル゚ヌテ
ル、ゞむ゜プロピル゚ヌテル、゚チレングリコヌ
ルゞメチル゚ヌテルなどの゚ヌテル類ニトロメ
タン、ニトロ゚タン、ニトロプロパンなどのニト
ロアルカン類アセトン、メチル゚チルケトン、
メチルむ゜ブチルケトンなどのアルキルケトン
類ゞクロルメタン、クロロホルム、ゞクロル゚
タン、四塩化炭玠などのハロゲン化アルカン類
ゞクロル゚チレン、トリクロル゚チレンなどのハ
ロゲン化アルケン類ホルムアミド、ゞメチルホ
ルムアミド、アセトアミドなどの酞アミド類ベ
ンれン、トル゚ン、クロルベンれン、ニトロベン
れンなどの芳銙族アルカン類−ヘキサン、ヘ
プタンなどのアルカン類シクロヘキサンなどの
脂環匏アルカン類スルホランたたはゞメチル
スルホキシド等があげられる。これらの溶媒は
皮以䞊混合しお甚いるこずもできる。たた詊薬ず
しお䜿甚されるスルフオン酞類が反応枩床で液䜓
である堎合には、それ自䜓を溶媒ずしお䜿甚する
こずもできる。そしお、これらの溶媒は実質的に
無氎の状態で䜿甚するのが奜たしい。
The reaction is usually carried out in a suitable solvent. Such a solvent is not particularly limited as long as it does not adversely affect the reaction; for example, the lower alcohol used in the reaction can be used as is, as well as nitriles such as acetonitrile and propionitrile;
Organic carboxylic acids and their esters such as formic acid, acetic acid, propionic acid, and trifluoroacetic acid; Ethers such as dioxane, tetrahydrofuran, diethyl ether, diisopropyl ether, and ethylene glycol dimethyl ether; Nitroalkanes such as nitromethane, nitroethane, and nitropropane; Acetone , methyl ethyl ketone,
Alkyl ketones such as methyl isobutyl ketone; halogenated alkanes such as dichloromethane, chloroform, dichloroethane, carbon tetrachloride;
Halogenated alkenes such as dichloroethylene and trichlorethylene; Acid amides such as formamide, dimethylformamide, and acetamide; Aromatic alkanes such as benzene, toluene, chlorobenzene, and nitrobenzene; Alkanes such as n-hexane and heptane; Examples include alicyclic alkanes such as cyclohexane; sulfolane; and dimethyl sulfoxide. These solvents are 2
It is also possible to use a mixture of two or more species. Furthermore, when the sulfonic acid used as a reagent is liquid at the reaction temperature, it can also be used itself as a solvent. These solvents are preferably used in a substantially anhydrous state.

反応枩床に特に限定はなく通垞反応は−30℃乃
至80℃、特に䜎枩で行うのが奜たしいがそれ以䞊
たたはそれ以䞋でも反応は進行する。
There is no particular limitation on the reaction temperature, and the reaction is usually carried out preferably at -30°C to 80°C, especially at a low temperature, but the reaction will proceed at higher or lower temperatures.

反応に芁する時間は䞻ずしお出発物質、詊薬、
溶媒等の皮類、詊薬の量、反応枩床等によ぀おも
異なり数分乃至数十時間である。
The time required for the reaction mainly depends on the starting materials, reagents,
The time required varies depending on the type of solvent, amount of reagent, reaction temperature, etc., and ranges from several minutes to several tens of hours.

反応終了埌、目的化合物は垞法によ぀お反応混
合物から採取される。䟋えば反応混合物に氷氎を
加えた埌、反応混合物の液性をPH〜たたは
〜に調敎する。析出する結晶を取するか、た
たは析出前に所望の造塩基質を加えお䞭和し所望
の塩ずしお採取するこずができる。この結晶を氎
で掗぀た埌枛圧で也燥するこずによ぀お目的化合
物が埗られる。このものは必芁ならば垞法䟋えば
再沈柱法等によ぀お曎に粟補するこずができる。
After the reaction is completed, the target compound is collected from the reaction mixture by a conventional method. For example, after adding ice water to the reaction mixture, adjust the liquid nature of the reaction mixture to PH3-4 or 6.
Adjust to ~7. The precipitated crystals can be collected, or the desired base-forming substance can be added to neutralize the crystals before precipitation and the desired salt can be collected. The target compound is obtained by washing the crystals with water and drying them under reduced pressure. If necessary, this product can be further purified by conventional methods such as reprecipitation.

なお、原料化合物の前蚘匏を有する−
ACAが塩である堎合に、目的化合物の前蚘䞀般
匏を有する化合物の塩は、反応条件等の圱
響により原料化合物の塩ずは異なる塩の圢で採取
されるこずがある。
In addition, 7- having the above formula () of the raw material compound
When ACA is a salt, the salt of the target compound having the general formula () may be collected in a salt form different from the salt of the starting compound depending on the reaction conditions and the like.

曎に、前蚘䞀般匏を有する化合物が遊離
の圢で採取された堎合は、必芁に応じお垞法によ
り塩の圢に倉換するこずができる。たた、前蚘䞀
般匏を有する化合物が塩の圢で採取された
堎合は、必芁に応じお垞法により遊離の圢に倉換
するこずもでき、曎に埗られた遊離の圢を別の所
望の塩に倉換するこずもできる。これらの倉換は
それぞれの生成物を単離するこずなく、続けお行
なうこずもできる。
Furthermore, when the compound having the general formula () is collected in a free form, it can be converted into a salt form by a conventional method if necessary. Furthermore, when the compound having the general formula () is collected in the form of a salt, it can be converted into a free form by a conventional method if necessary, and the obtained free form can be converted into another desired form. It can also be converted into salt. These transformations can also be carried out sequentially without isolation of the respective products.

次に本発明の方法を実斜䟋をあげお具䜓的に説
明するが、本発明の方法はこれによ぀お限定され
るものではない。
Next, the method of the present invention will be specifically explained with reference to Examples, but the method of the present invention is not limited thereto.

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 (1) −アミノ−−アセトキシメチル−−セ
プム−−カルボン酞−ACA5.4に
メタノヌル0.85mlおよびゞクロルメタン30mlを
加えお冷华した埌、メタンスルフオン酞7.8ml
を加えた。反応混合物を14〜17℃で時間撹拌
した。反応終了埌、反応混合物を氷氎䞭に泚入
し、次いで10氎酞化ナトリりム氎溶液を加え
おPH3.5に調敎した。生成した結晶を取し、
冷氎で掗浄埌、也燥するず粗−アミノ−−
メトキシメチル−−セプム−−カルボン
酞・メタンスルフオン酞塩2.6が埗られた。
Example 1 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid (1) 5.4 g of 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-ACA) and 0.85 g of methanol ml and dichloromethane 30ml and after cooling, methanesulfonic acid 7.8ml
added. The reaction mixture was stirred at 14-17°C for 2 hours. After the reaction was completed, the reaction mixture was poured into ice water, and then a 10% aqueous sodium hydroxide solution was added to adjust the pH to 3.5. Take the generated crystals,
After washing with cold water and drying, the crude 7-amino-3-
2.6 g of methoxymethyl-3-cephem-4-carboxylic acid methanesulfonate was obtained.

NMRスペクトルCF3COOH、Ύppn 3.123H、、H3 SO3H 3.633H、、−CH2OCH3  3.772H、、䜍の−H2 − 4.862H、、−H2 OCH3 5.432H、、䜍および䜍の IRスペクトルΜNujol maxcm-1 3160−NH2 1800、β−ラクタム 1620−COOH 1540〜1520−NH2 1190CH2SO3H 1100−CH2OCH3 (2) (1)で埗られた粗−アミノ−−メトキシメ
チル−−セプム−−カルボン酞・メタン
スルフオン酞塩を氎15mlに懞濁し、次いで塩酞
を加えお溶解した埌、10氎酞化ナトリりム氎
溶液を加えおPH3.5に調敎した。析出する結晶
を取し、氎掗埌也燥するず衚蚘化合物1.48
が埗られた。
NMR spectrum ( CF3COOH , ÎŽ: ppn ) 3.12 (3H, S, CH3SO3H ) 3.63 (3H, S , -CH2OCH3 ) 3.77 (2H, S, -CH2 at the 2nd position −) 4.86 (2H, S, −CH 2 OCH 3 ) 5.43 (2H, S, H at the 6th and 7th positions) IR spectrum (ΜNujol maxcm −1 ) 3160 (−NH 2 ) 1800 (c=0, β -lactam) 1620 (-COOH) 1540-1520 (-NH 2 ) 1190 (CH 2 SO 3 H) 1100 (-CH 2 OCH 3 ) (2) Crude 7-amino-3-methoxy obtained in (1) Methyl-3-cephem-4-carboxylic acid methanesulfonate was suspended in 15 ml of water, then hydrochloric acid was added to dissolve it, and 10% aqueous sodium hydroxide solution was added to adjust the pH to 3.5. When the precipitated crystals are collected, washed with water and dried, 1.48g of the listed compound is obtained.
was gotten.

NMRスペクトルCF3COH、Ύppn 3.633H、、−CH2OCH3  3.772H、、䜍の−H2 − 4.862H、、−H2 OCH3 5.432H、、䜍および䜍の IRスペクトルΜNujol maxcm-1 3160−NH2 1800、β−ラクタム 1620−COOH 1540〜1520−NH2 1100−CH2OCH3 元玠分析倀 C9H12O4N2Sずしお 蚈算倀、44.26、4.95、11.47
、13.12 実枬倀、43.93、4.82、11.23
、13.13 実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 −アミノ−−アセトキシメチル−−セフ
゚ム−−カルボン酞−ACA0.27にメ
タノヌル0.4mlおよびゞクロルメタン22mlを加え
冷华した埌、硫酞0.49を加えた。反応混合物を
10℃で撹拌した。反応経過をHPLCでチ゚ツクし
た。反応終了埌、反応混合物を以䞋、実斜䟋の
(1)および(2)の方法に準じお凊理するず衚蚘化合物
0.05が埗られた。
NMR spectrum CF 3 COH, Ύ: ppn ) 3.63 (3H, S, -CH 2 OCH 3 ) 3.77 (2H, S, -CH 2 - at the 2nd position) 4.86 (2H, S, -CH 2 OCH 3 ) 5.43 (2H, S, H at positions 6 and 7) IR spectrum (ΜNujol maxcm -1 ) 3160 (-NH 2 ) 1800 (c=0, β-lactam) 1620 (-COOH) 1540 ~ 1520 (-NH 2 ) 1100 (-CH 2 OCH 3 ) Elemental analysis value C 9 H 12 O 4 N 2 S Calculated value C, 44.26; H, 4.95; N, 11.47;
S, 13.12 Actual value C, 43.93; H, 4.82; N, 11.23;
S, 13.13 Example 2 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 0.27 g of 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-ACA) and 0.4 g of methanol After cooling, 0.49 g of sulfuric acid was added. reaction mixture
Stir at 10°C. The progress of the reaction was checked by HPLC. After the reaction was completed, the reaction mixture was treated as described in Example 1 below.
When treated according to methods (1) and (2), the listed compound
0.05g was obtained.

NMRスペクトルおよびIRスペクトルは、実斜
䟋で埗られたものず同じであ぀た。
The NMR and IR spectra were the same as those obtained in Example 1.

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 −アミノ−−アセトキシメチル−−セフ
゚ム−−カルボン酞−ACA0.54にメ
タノヌル0.49mlおよびトリクロル゚チレンmlを
加えお冷华した埌、メタンスルフオン酞mlを加
えた。反応混合物を冷蔵庫−℃䞭に24時間
攟眮した。反応終了埌、反応混合物を以䞋、実斜
䟋の(1)および(2)の方法に準じお凊理するず衚蚘
化合物0.2が埗られた。
Example 3 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 0.54 g of 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-ACA), 0.49 ml of methanol and trichlor After adding 5 ml of ethylene and cooling, 1 ml of methanesulfonic acid was added. The reaction mixture was left in the refrigerator (-8°C) for 24 hours. After the reaction was completed, the reaction mixture was treated according to methods (1) and (2) of Example 1 to obtain 0.2 g of the title compound.

NMRスペクトルおよびIRスペクトルは、実斜
䟋で埗られたものず同じであ぀た。
The NMR and IR spectra were the same as those obtained in Example 1.

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 −アミノ−−アセトキシメチル−−セフ
゚ム−−カルボン酞−ACA2.72を四
塩化炭玠13.6mlおよびメタノヌル2.05mlに加えお
−20℃に冷华した埌、゚タンスルフオン酞9.8ml
を加えた。反応混合物を冷蔵庫䞭−℃に
41.5時間攟眮した。反応終了埌、反応混合物を砕
氷䞭に投入し、次いで10氎酞化ナトリりム氎溶
液を加えおPH3.5に調敎した。生成した結晶を
取し、冷氎で掗浄埌、也燥するず粗−アミノ−
−メトキシメチル−−セプム−−カルボ
ン酞・゚タンスルフオン酞塩1.17が埗られた。
Example 4 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 2.72 g of 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-ACA) was dissolved in 13.6 ml of carbon tetrachloride. and 9.8 ml of ethanesulfonic acid after cooling to −20°C in addition to 2.05 ml of methanol.
added. Place the reaction mixture in the refrigerator (-8°C)
It was left for 41.5 hours. After the reaction was completed, the reaction mixture was poured into crushed ice, and then a 10% aqueous sodium hydroxide solution was added to adjust the pH to 3.5. The formed crystals are collected, washed with cold water, and dried to give crude 7-amino-
1.17 g of 3-methoxymethyl-3-cephem-4-carboxylic acid ethanesulfonate was obtained.

䞊蚘で埗られた粗−アミノ−−メトキシメ
チル−−セプム−−カルボン酞・゚タンス
ルフオン酞塩1.0に氷氎mlを加え、次いで撹
拌䞋で塩酞mlを加えお溶解した。反応混合物に
掻性炭0.2を加えお脱色過し、埗られた液
に20氎酞化ナトリりム氎溶液を加えおPH3.5に
調敎した。析出する結晶を取し、氎掗埌也燥す
るず衚蚘化合物0.57が埗られた。
5 ml of ice water was added to 1.0 g of the crude 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid ethanesulfonate obtained above, and then 1 ml of hydrochloric acid was added and dissolved under stirring. 0.2 g of activated carbon was added to the reaction mixture to decolorize the mixture, and a 20% aqueous sodium hydroxide solution was added to the resulting liquid to adjust the pH to 3.5. The precipitated crystals were collected, washed with water, and then dried to obtain 0.57 g of the title compound.

NMRスペクトルおよびIRスペクトルは、実斜
䟋で埗られたものず同じであ぀た。
The NMR and IR spectra were the same as those obtained in Example 1.

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 トリフルオルメタンスルフオン酞21.6にメタ
ノヌル2.05mlを氷氎冷华䞋で加えお混合した。䞊
蚘の溶液を、−アミノ−−アセトキシメチル
−−セプム−−カルボン酞−ACA
2.72を四塩化炭玠18mlに懞濁し、−15℃に冷华
した溶液に加えた。反応混合物を冷蔵庫−
℃䞭に攟眮した。反応混合物を24時間埌に、
HPLCを甚いお分析した結果、衚蚘化合物が25
の収率で生成されおいるこずを確認した。
Example 5 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 2.05 ml of methanol was added to 21.6 g of trifluoromethanesulfonic acid under cooling with ice water and mixed. The above solution was converted into 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-ACA).
2.72 g was suspended in 18 ml of carbon tetrachloride and added to the solution cooled to -15°C. Store the reaction mixture in the refrigerator (-8
℃). After 24 hours, the reaction mixture was
As a result of analysis using HPLC, the listed compound was 25%
It was confirmed that the product was produced with a yield of .

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 −アミノ−−アセトキシメチル−−セフ
゚ム−−カルボン酞0.27にゞクロルメタン
2.2mlおよびメタノヌル0.2mlを加え、次いで10〜
12℃で゚チル硫酞0.63を加えた。反応混合物を
250分埌にHPLCを甚いお分析した結果、衚蚘化
合物が13.6の収率で生成されおいるこずを確認
した。
Example 6 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 0.27 g of 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid in dichloromethane
Add 2.2 ml and 0.2 ml of methanol, then 10~
At 12°C, 0.63 g of ethyl sulfate was added. reaction mixture
As a result of analysis using HPLC after 250 minutes, it was confirmed that the title compound was produced at a yield of 13.6%.

実斜䟋  −アミノ−−メトキシメチル−−セプ
ム−−カルボン酞 25発煙硫酞10をゞクロル゚チレン13.6mlに
混合し、次いで冷华䞋でメタノヌルmlを適加し
た。䞊蚘の溶液を、−アミノ−−アセトキシ
メチル−−セプム−−カルボン酞−
ACA2.72をゞクロル゚チレン13.6mlおよびメ
タノヌル2.05mlに溶解した溶液に−30℃で加え、
次いで冷蔵庫−℃䞭に攟眮した。反応混合
物を16時間埌に、HPLCを甚いお分析した結果、
衚蚘化合物が25.1の収率で生成されおいるこず
を確認した。
Example 7 7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid 10 g of 25% oleum was mixed with 13.6 ml of dichloroethylene, and then 2 ml of methanol was added under cooling. The above solution was mixed with 7-amino-3-acetoxymethyl-3-cephem-4-carboxylic acid (7-
ACA) was added to a solution of 2.72 g dissolved in 13.6 ml of dichloroethylene and 2.05 ml of methanol at -30°C.
Then, it was left in a refrigerator (-8°C). After 16 hours, the reaction mixture was analyzed using HPLC.
It was confirmed that the title compound was produced at a yield of 25.1%.

Claims (1)

【特蚱請求の範囲】  匏 で瀺される−アミノ−−アセトキシメチル−
−セプム−−カルボン酞たたはその塩にア
ルキルスルフオン酞、アルキル硫酞、ハロゲン眮
換アルキルスルフオン酞たたは硫酞の存圚䞋、䜎
玚アルコヌルを反応させるこずを特城ずする䞀般
匏 〔匏䞭、は䜎玚アルキル基を瀺す。〕で瀺され
る−アルコキシメチルセフアロスポリンたたは
その塩の補造方法。
[Claims] 1 formula 7-amino-3-acetoxymethyl-
A general formula characterized by reacting 3-cephem-4-carboxylic acid or a salt thereof with a lower alcohol in the presence of an alkylsulfonic acid, an alkylsulfuric acid, a halogen-substituted alkylsulfonic acid, or sulfuric acid. [In the formula, R represents a lower alkyl group. ] A method for producing 3-alkoxymethylcephalosporin or a salt thereof.
JP3715283A 1983-03-07 1983-03-07 Preparation of 3-alkoxymethylcephalosporin Granted JPS59163387A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3715283A JPS59163387A (en) 1983-03-07 1983-03-07 Preparation of 3-alkoxymethylcephalosporin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3715283A JPS59163387A (en) 1983-03-07 1983-03-07 Preparation of 3-alkoxymethylcephalosporin

Publications (2)

Publication Number Publication Date
JPS59163387A JPS59163387A (en) 1984-09-14
JPH0454674B2 true JPH0454674B2 (en) 1992-08-31

Family

ID=12489631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3715283A Granted JPS59163387A (en) 1983-03-07 1983-03-07 Preparation of 3-alkoxymethylcephalosporin

Country Status (1)

Country Link
JP (1) JPS59163387A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262744B1 (en) * 1986-10-02 1994-03-23 Asahi Kasei Kogyo Kabushiki Kaisha A process for preparing 3-alkoxymethylcephalosphorins
JP2612493B2 (en) * 1988-05-24 1997-05-21 旭化成工業株匏䌚瀟 Method for producing 3-substituted methyl-3-cephem-4-carboxylic acids
DK0485204T3 (en) 1990-11-07 1995-10-16 Sankyo Co Process for Preparation of 3-Alkoxymethyl-Cephalosporin Derivatives
AT401177B (en) * 1993-10-22 1996-07-25 Biochemie Gmbh PROCESS FOR THE PREPARATION OF 7-AMINO-3-CEPHEM-4-CARBONIC ACID DERIVATIVES
JPH09249983A (en) * 1996-03-13 1997-09-22 Otsuka Chem Co Ltd Production of 3-alkoxymethylcephem compound
AT406773B (en) * 1998-04-02 2000-08-25 Biochemie Gmbh NEW SALT OF 7- (2- (AMINOTHIAZOL-4YL) -2-
EP2758407A1 (en) 2011-09-20 2014-07-30 Dhanuka Laboratories Ltd. An improved process for cefpodoxime acid
EP3426663B1 (en) 2016-03-07 2020-01-29 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins

Also Published As

Publication number Publication date
JPS59163387A (en) 1984-09-14

Similar Documents

Publication Publication Date Title
JPH027315B2 (en)
JPH0454674B2 (en)
JPS6360992A (en) Novel oxime derivative of 3-substituted 7-aminothiazolylacetamide cephalosporinic acid
US4902793A (en) Process for preparing 3-alkoxymethylcephalosporins
JP3751880B2 (en) Method for producing high-purity cefpodoxime proxetil
JP4022070B2 (en) Novel thiazole compound and method for producing the same
KR100392409B1 (en) A process for preparing cephalosporine derivatives using new thiazole compound
US4012381A (en) Process for preparing cephalosporins and intermediates
JPH0134227B2 (en)
JP2595605B2 (en) Method for producing 2-substituted oxyimino-3-oxobutyric acid
CA1236089A (en) Ceftazidime
KR890002107B1 (en) Method for preparing cephalosporin derivative
EP0153874A2 (en) Cephalosporin intermediates and their preparation
JPS63115887A (en) Production of 7-amino-3-alkoxymethylcephalosporins
JPH0587512B2 (en)
JP2661810B2 (en) Method for producing 7-amino-3-chloromethyl-3-cephem derivative
US4143037A (en) Thiohydrazoazetidinones
EP0102687B1 (en) Process for the preparation of a 4-halo-2-hydroxyimino-acetoacetic acid ester
KR800000792B1 (en) Process for preparing cephem derivatives
KR890002215B1 (en) Process for preparing cephem derivatives
KR890000523B1 (en) Process for preparing cephalosporin derivatives
JPH02138282A (en) Production of cephalosporin compound
JPH0358991A (en) Production of 7-aminocephem compound
JPS6135198B2 (en)
JPS60248691A (en) Novel preparation of cephalosporin compound and its intermediate